Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Proteostasis Therapeutics Inc. (PTI)

1.09   0.01 (0.93%) 11-19 16:00
Open: 1.08 Pre. Close: 1.08
High: 1.1 Low: 1.06
Volume: 887,237 Market Cap: 56M
Proteostasis Therapeutics Inc operates in the healthcare sector of United States. Its business involves the discovery and development of therapeutics to correct the imbalance of the protein biosynthesis process.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.101 - 1.105 1.105 - 1.11
Low: 1.049 - 1.053 1.053 - 1.058
Close: 1.081 - 1.089 1.089 - 1.097

Technical analysis

as of: 2019-11-19 4:29:15 PM
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 1.33     One year: 1.56
Support: Support1: 0.87    Support2: 0.70
Resistance: Resistance1: 1.14    Resistance2: 1.33
Pivot: 0.95
Moving Average: MA(5): 1.08     MA(20): 0.92
MA(100): 0.85     MA(250): 1.95
MACD: MACD(12,26): 0.07     Signal(9): 0.05
Stochastic oscillator: %K(14,3): 82.46     %D(3): 81.58
RSI: RSI(14): 68.78
52-week: High: 5.92  Low: 0.61  Change(%): -80.8
Average Vol(K): 3-Month: 65881  10-Days: 165148

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
PTI has closed below upper band by 19.6%. Bollinger Bands are 110.8% wider than normal. The large width of the bands suggest high volatility as compared to PTI's normal range. The bands have been in this wide range for 5 bars. This is a sign that the current trend might continue.

Headline News

Navigator diz não haver justificação para a greve marcada de 13 a 16 de novembro
A The Navigator Company considera não haver justificação para a greve que os trabalhadores pretendem realizar entre os dias 13 e 16 de novembro, tendo em conta a redução de horários de trabalho e aumentos remuneratórios registados.

Proteostasis Therapeutics (PTI) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
Proteostasis (PTI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Global Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 51.13
Shares Float (M) 34.45
% Held by Insiders 17.52
% Held by Institutions 79.59
Shares Short (K) 2530
Shares Short P. Month (K)

Stock Financials

EPS -1.286
Book Value (p.s.) 1.370
PEG Ratio
Profit Margin
Operating Margin -1329.88
Return on Assets (ttm) -52.6
Return on Equity (ttm) -117.7
Qtrly Rev. Growth
Gross Profit (p.s.) 0.056
Sales Per Share
EBITDA (p.s.) -1.273
Qtrly Earnings Growth
Operating Cash Flow (M) -60.90
Levered Free Cash Flow (M) -35.86

Stock Valuations

P/E -0.85
P/E Growth Ratio 0.01
P/BV 0.80
P/S 10.90
P/CF -0.92

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.